GlyCosmos Portal

GlyCOVID

GlyCOVID is a dataset of RDFized COVID-19 data related to glycans. Resources will be added incrementally as publications are curated.

Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series.
Heidepriem J, et al.
Pathogens. 2021; 10(4):438. https://doi.org/10.3390/pathogens10040438

A longitudinal analysis of three COVID-19 patients with moderate (#1) and mild disease (#2 and #3) was published. Antibody serum responses were analyzed using spike glycoprotein enzyme linked immunosorbent assay (ELISA), full-proteome peptide, and glycan microarrays. In this Glycovid dataset, the data from these glycan microarray experiments have been RDFized. Fluorescence intensity is given in arbitrary fluorescence units (AFU) as reported in this publication.

Source	Last Updated
PSICQUIC	March 30, 2022

Displaying entries **1301 - 1325** of **4050** in total

« First

‹ Prev

…

49

50

51

52

53

54

55

56

57

…

Next ›

Last »
Antibody	Patient	Onset (days)	Symptom	GlyTouCan ID	Arbitrary Fluorescence Units (AFU) ▲
IgM	Patient 1	22	moderate	G36191CD	89
IgG	Patient 1	6	moderate	G39023AU	89
IgM	Patient 3	-180	mild	G25407RZ	89
IgM	Patient 3	-180	mild	G36544AC	89
IgM	Patient 3	11	mild	G57449OF	89
IgM	Patient 3	11	mild	G82348BZ	89
IgG	Patient 1	10	moderate	G39023AU	90
IgM	Patient 1	10	moderate	G36544AC	90
IgM	Patient 1	10	moderate	G81315DD	90
IgM	Patient 1	10	moderate	G92022ML	90
IgG	Patient 2	24	mild	G43648DB	90
IgG	Patient 2	3	mild	G17140UR	90
IgG	Patient 3	4	mild	G61399NC	90
IgG	Patient 3	4	mild	G81315DD	90
IgM	Patient 3	4	mild	G82942ZJ	90
IgG	Patient 4	12	mild	G12200GB	90
IgG	Patient 1	22	moderate	G60761LT	91
IgM	Patient 1	22	moderate	G58547FH	91
IgG	Patient 2	15	mild	G09609EN	91
IgG	Patient 2	15	mild	G17140UR	91
IgG	Patient 2	24	mild	G17140UR	91
IgM	Patient 2	15	mild	G07483YN	91
IgM	Patient 2	3	mild	G68461PT	91
IgM	Patient 3	-180	mild	G14844CX	91
IgM	Patient 3	11	mild	G00054MO	91